| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
RDNT sits in the Life Sciences Tools & Services industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.21M | $76.88M | - | |
| CEO | 507.2K | $29.73M | - | |
| COO | 261.2K | - | - | |
| VP | 200.2K | - | - | |
| Dir | 177.0K | $9.54M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 3, 2017 | Kaminsky Sandy Nyholm | 10% Owner | Sell | 1,100,000 | $10.95 | $12,045,000.00 | -17.6% | |
| Sep 20, 2017 | Levitt Lawrence L58 | Director | Sell | 8,811 | $10.82 | $95,335.02 | -4.4% | |
| Sep 19, 2017 | Levitt Lawrence L58 | Director | Sell | 6,189 | $11.04 | $68,326.56 | -3.0% | |
| Sep 19, 2017 | Linden Jeffrey L | Executive Vice President | Sell | 18,192 | $10.95 | $199,202.40 | -1.9% | |
| Sep 12, 2017 | Sherman Michael L Md | Director | Sell | 11,965 | $11.02 | $131,854.30 | -4.0% | |
| Sep 11, 2017 | Sherman Michael L Md | Director | Sell | 8,035 | $11.02 | $88,545.70 | -2.6% | |
| Sep 7, 2017 | Swartz David L | Director | Sell | 25,000 | $10.98 | $274,571.25 | -8.5% | |
| Sep 6, 2017 | Linden Jeffrey L | Executive Vice President | Sell | 10,000 | $10.72 | $107,200.00 | -1.0% | |
| Aug 30, 2017 | Stolper Mark | Executive VP And CFO | Sell | 10,000 | $10.19 | $101,900.00 | -6.4% | |
| Aug 23, 2017 | Linden Jeffrey L | Executive Vice President | Sell | 10,104 | $9.91 | $100,130.64 | -1.0% |